What value do cell cycle inhibitors have in the treatment of myelodysplastic syndrome?

Maria Siddiqui, Gautam Borthakur

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)775-778
Number of pages4
JournalExpert opinion on pharmacotherapy
Volume24
Issue number7
DOIs
StatePublished - 2023

Keywords

  • cell cycle inhibitors
  • hypomethylating agents
  • intensive chemotherapy
  • lenalidomide
  • Myelodysplastic syndrome

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this